The Power of LC-MS Based Multiomics: Exploring Adipogenic Differentiation of Human Mesenchymal Stem/Stromal Cells

Abstract

The molecular study of fat cell development in the human body is essential for our understanding of obesity and related diseases. Mesenchymal stem/stromal cells (MSC) are the ideal source to study fat formation as they are the progenitors of adipocytes. In this work, we used human MSCs, received from surgery waste, and differentiate them into fat adipocytes. The combination of several layers of information coming from lipidomics, metabolomics and proteomics enabled network analysis of the biochemical pathways in adipogenesis. Simultaneous analysis of metabolites, lipids and proteins in cell culture is challenging due to the compound's chemical difference so that most studies involve separate analysis with unimolecular strategies. In this study, we employed a multimolecular approach using a two-phase extraction to monitor the crosstalk between lipid metabolism and protein-based signaling in a single sample (~10 5 cells). We developed an innovative analytical workflow including standardization with in-house produced 13 C-isotopically labeled compounds, hyphenated high-end mass spectrometry (high-resolution Orbitrap MS) and chromatography (HILIC, RP) for simultaneous untargeted screening and targeted quantification. Metabolite and lipid concentrations ranged over 3-4 orders of magnitude and were detected down to the low fmol (absolute on column) level. Biological validation and data interpretation of the multiomics workflow was performed based on proteomics network reconstruction, metabolic modelling (MetaboAnalyst 4.0) and pathway analysis (OmicsNet). Comparing MSCs and adipocytes, we observed significant regulation of different metabolites and lipids such as triglycerides, gangliosides and carnitine with 113 fully reprogrammed pathways. The observed changes are in accordance with literature findings dealing with adipogenic differentiation of MSC. These results are a proof of principle for the power of multimolecular extraction combined with orthogonal LC-MS assays and network construction. Considering the analytical and biological validation performed in this study, we conclude that the proposed multiomics workflow is ideally suited for comprehensive follow-up studies on adipogenesis and is fit for purpose for different applications.

Plasma proteomic profile associated with platelet dysfunction after trauma

“…Controlling for this can be difficult, as patients have differing blood volumes, and crystalloid fluids are known to rapidly redistribute into the interstitium. We chose to control for hemodilution by normalizing the mass spectrometry peak intensity areas (using the standard definition 17,18 ) to the patient's corresponding total plasma protein concentration, as the best possible method from available data.…”

A combined flow injection/reversed phase chromatography – high resolution mass spectrometry workflow for accurate absolute lipid quantification with13C- internal standards

“…The number of accurately quantified lipid species has been limited to the number of external calibrants. 26,27 In order to overcome this limitation, a workflow has been designed to quantify LILY on an day-to-day routine prior to RP-LC-HRMS analysis of samples. This strategy enables to implement different calibration strategies within one lipidomics workflow including internal standardization without external standardization.…”

Recurrent Topics in Mass Spectrometry-Based Metabolomics and Lipidomics—Standardization, Coverage, and Throughput

“…Such phase separation strategies reduce the sample amount needed and pave the way for direct-infusion and LC-MS based multi-omics (metabolomics, lipidomics, and proteomics) from a single sample. 226 , 273 Additional lipidome coverage can be achieved using approaches such as (1) 3-phase extraction separating neutral lipids in the upper phase and glycerophospholipids in the middle organic phase 274 or (2) the combination of two-phase liquid extraction with MTBE combined with SPE. 271 In order to understand metabolite action on the subcellular level, experimental resolution of subcellular metabolism is needed.…”